Amzak Health — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Nervoniknervonik.cominApr 2026 · $52.5M
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesShangBay Capital LLCUS Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.